Plaintiffs of the first two Xarelto bellwether cases have now decided to approach the United States Court of Appeals for the Fifth Circuit presenting appeals to overturn the verdicts of their cases. This decision followed Judge Fallon's decision of denying new trials to both the plaintiffs in September. Their trials were a part of the 18,000+ lawsuits filed in the U.S. District Court, Eastern District of Louisiana MDL 2592 with additional cases filed in the federal and state courts across the country. Both appeals have a few common and individual facts. The defendants' stand regarding the safety and efficacy of Xarelto stays, stating that Xarelto's FDA-approved label contains accurate, science-based information on the benefits and risks of this life-saving medicine.
Recent News
Roundup Lawsuits in New Jersey Seek Centralization
03/04/2024 - 17:33
A request has been filed by a group of plaintiffs urging the consolidation of all Roundup lawsuits related to non-Hodgkin’s lymphom…
Learn More
Baltimore Settles in Walmart Opioid Cases
03/03/2024 - 20:48
The mayor of Baltimore, representing the City, has endorsed a statewide settlement with Walmart to address the corporation's allege…
Learn More
Opioid Crisis: Fentanyl and Meth Drive 'Fourth Wave…
02/27/2024 - 21:02
The United States is currently grappling with what some experts identify as the "fourth wave" of the opioid epidemic, presenting in…
Learn More
Oregon Re-evaluates Decriminalization Amid Opioid Crisis
02/20/2024 - 16:46
In 2020, Oregonians approved a groundbreaking ballot measure, known as Measure 110, establishing the most progressive drug law in t…
Learn More